CRISPR Gene Editing Market
CRISPR Gene Editing Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
CRISPR Gene Editing Market Size and Growth
The CRISPR gene editing market is experiencing robust growth, driven by advancements in biotechnology and increased applications in therapeutics and agriculture. The market size is projected to reach approximately $6 billion by 2025, fueled by rising investments and collaborations among research institutions and biopharmaceutical companies to develop innovative gene editing solutions.
Companies Covered
(Covid 19 Impact Covered)
◍ Abcam, Inc.
◍ Applied StemCell, Inc.
◍ Cellecta, Inc.
◍ CRISPR Therapeutics AG
◍ GeneCopoeia, Inc.
◍ GenScript Biotech Corporation
◍ Horizon Discovery Group PLC
◍ Integrated DNA Technologies, Inc.
◍ Merck KGaA
◍ New England Biolabs, Inc.
The CRISPR gene editing market features key players like Abcam, Applied StemCell, and CRISPR Therapeutics, focusing on research tools and therapeutic applications. They innovate CRISPR technologies, provide reagents, and expand access, driving market growth. Notable sales figures include:
- New England Biolabs: ~$500 million
- Merck KGaA: ~$28 billion total revenue (2022).
Request Sample Report
Market Segmentation
By Application
Agricultural
Biomedical
Industrial
Others
By Product
◍ gRNA Design and Vector Construction
Cell Line and Engineering
Screening Services
Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
